Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Elotuzumab – Anti-CS1 Antibody for Multiple Myeloma

Common forms of blood cancer; multiple myeloma is the second most common haematological malignancy.



  • Multiple mylemoa
  • Formation of blood cells.
  • Multiple myeloma
  • Common forms of blood cancer
  • Some of the events that take place in the bone

Go Top